[HTML][HTML] “Specificity determinants” improve therapeutic indices of two antimicrobial peptides piscidin 1 and dermaseptin S4 against the Gram-negative pathogens …

Z Jiang, AI Vasil, ML Vasil, RS Hodges - Pharmaceuticals, 2014 - mdpi.com
A new class of antimicrobial agents with lower rates of resistance and different targets is
urgently needed because of the rapidly increasing resistance to classical antibiotics …

[PDF][PDF] “Specificity Determinants” Improve Therapeutic Indices of Two Antimicrobial Peptides Piscidin 1 and Dermaseptin S4 against the Gram-negative Pathogens …

Z Jiang, AI Vasil, ML Vasil, RS Hodges - Pharmaceuticals, 2014 - Citeseer
A new class of antimicrobial agents with lower rates of resistance and different targets is
urgently needed because of the rapidly increasing resistance to classical antibiotics …

[PDF][PDF] “Specificity Determinants” Improve Therapeutic Indices of Two Antimicrobial Peptides Piscidin 1 and Dermaseptin S4 against the Gram-negative Pathogens …

Z Jiang, AI Vasil, ML Vasil, RS Hodges - Pharmaceuticals, 2014 - pdfs.semanticscholar.org
A new class of antimicrobial agents with lower rates of resistance and different targets is
urgently needed because of the rapidly increasing resistance to classical antibiotics …

[PDF][PDF] “Specificity Determinants” Improve Therapeutic Indices of Two Antimicrobial Peptides Piscidin 1 and Dermaseptin S4 against the Gram-negative Pathogens …

Z Jiang, AI Vasil, ML Vasil, RS Hodges - Pharmaceuticals, 2014 - scienceopen.com
A new class of antimicrobial agents with lower rates of resistance and different targets is
urgently needed because of the rapidly increasing resistance to classical antibiotics …

" Specificity Determinants" Improve Therapeutic Indices of Two Antimicrobial Peptides Piscidin 1 and Dermaseptin S4 against the Gram-negative Pathogens …

Z Jiang, AI Vasil, ML Vasil… - Pharmaceuticals …, 2014 - search.ebscohost.com
A new class of antimicrobial agents with lower rates of resistance and different targets is
urgently needed because of the rapidly increasing resistance to classical antibiotics …

[HTML][HTML] “Specificity Determinants” Improve Therapeutic Indices of Two Antimicrobial Peptides Piscidin 1 and Dermaseptin S4 against the Gram-negative Pathogens …

Z Jiang, AI Vasil, ML Vasil, RS Hodges - Pharmaceuticals, 2014 - ncbi.nlm.nih.gov
A new class of antimicrobial agents with lower rates of resistance and different targets is
urgently needed because of the rapidly increasing resistance to classical antibiotics …

" Specificity Determinants" Improve Therapeutic Indices of Two Antimicrobial Peptides Piscidin 1 and Dermaseptin S4 Against the Gram-negative Pathogens …

Z Jiang, AI Vasil, ML Vasil, RS Hodges - Pharmaceuticals, 2014 - search.proquest.com
A new class of antimicrobial agents with lower rates of resistance and different targets is
urgently needed because of the rapidly increasing resistance to classical antibiotics …

" Specificity Determinants" Improve Therapeutic Indices of Two Antimicrobial Peptides Piscidin 1 and Dermaseptin S4 Against the Gram-negative Pathogens …

Z Jiang, AI Vasil, ML Vasil… - Pharmaceuticals (Basel …, 2014 - europepmc.org
A new class of antimicrobial agents with lower rates of resistance and different targets is
urgently needed because of the rapidly increasing resistance to classical antibiotics …

" Specificity Determinants" Improve Therapeutic Indices of Two Antimicrobial Peptides Piscidin 1 and Dermaseptin S4 Against the Gram-negative Pathogens …

Z Jiang, AI Vasil, ML Vasil… - Pharmaceuticals (Basel …, 2014 - pubmed.ncbi.nlm.nih.gov
A new class of antimicrobial agents with lower rates of resistance and different targets is
urgently needed because of the rapidly increasing resistance to classical antibiotics …

[PDF][PDF] “Specificity Determinants” Improve Therapeutic Indices of Two Antimicrobial Peptides Piscidin 1 and Dermaseptin S4 against the Gram-negative Pathogens …

Z Jiang, AI Vasil, ML Vasil, RS Hodges - Pharmaceuticals, 2014 - researchgate.net
A new class of antimicrobial agents with lower rates of resistance and different targets is
urgently needed because of the rapidly increasing resistance to classical antibiotics …